Potential New Approaches to Modifying Intestinal GLP-1 Secretion in Patients with Type 2 Diabetes Mellitus.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 1, doi. 10.2165/11595370-000000000-00000
- By:
- Publication type:
- Article
Works matching IS 11732563 AND DT 2012 AND VI 32 AND IP 1
Results: 6
1
2
Dose Proportionality and Pharmacokinetics of Fentanyl Buccal Soluble Film in Healthy Subjects.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 63, doi. 10.2165/11594670-000000000-00000
- By:
- Publication type:
- Article
3
Safety and Tolerability of High-Dose Budesonide/Formoterol via Turbuhaler® in Japanese Patients with Asthma.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 51, doi. 10.2165/11595440-000000000-00000
- By:
- Publication type:
- Article
4
Therapeutic Efficacy and Tolerability of the Topical Treatment of Inflammatory Conditions of the Oral Cavity with a Mouthwash Containing Diclofenac Epolamine.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 41, doi. 10.2165/11598170-000000000-00000
- By:
- Publication type:
- Article
5
Efficacy and Safety of Dutasteride in Chinese Adults with Symptomatic Benign Prostatic Hyperplasia.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 29, doi. 10.2165/11593750-000000000-00000
- By:
- Publication type:
- Article
6
Reduction in Healthcare and Societal Resource Utilization Associated with Cladribine Tablets in Patients with Relapsing-Remitting Multiple Sclerosis.
- Published in:
- Clinical Drug Investigation, 2012, v. 32, n. 1, p. 15, doi. 10.2165/11593310-000000000-00000
- By:
- Publication type:
- Article